Commentary · 31 Mar 2022
EditorialPublished 30 Dec 2021
Editorial Note on Interferon and GvHD
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For patients with hematological malignancies, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most successful and curative therapy option. Graft-versus-leukemia (GvL) effects and robust immunological reconstitution are two of the life-saving advantages of all-HSCT. The majority of patients, however, suffer Graft-vs-Host Disease (GvHD), which causes organ/tissue destruction in the skin, liver, and gastrointestinal system. As a result, substantial study on GvHD has been conducted, with IFNs being identified as a therapeutic target. Despite this, the pleiotropic nature of IFNs has hampered our efforts to achieve optimal GvHD management.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 26 Nov 2021
Editorial Note on Journal of Immunology and Microbiology
Editorial · 29 Oct 2021
Editorial Note to Flavonoids
Editorial · 29 Oct 2021
Editorial note on Macrophages
Editorial · 28 Oct 2021
Editorial Note on the Inflammatory
More from this journal
The newest in Journal of Immunology and Immunotherapy.
Research article · 17 Jan 2023
Relationship between Circulating Plasma Galectin-3 Levels and T-Cell Activation during Cervical Cancer Chemotherapy
Editorial · 30 Dec 2021
Innate Immunity in Initial Deviation of Metazoanst
Perspective · 27 Dec 2021
Infectious viruses at Maternal-Fetal Interface
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Immunology and Immunotherapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Charles Martins”

